With more than 3.8 million people diagnosed with diabetes in the UK and an estimated further 500,000 adults with type 2 diabetes who have the condition, but don’t even know it, DRWF is intent on its prime aim as a medical research charity – to find a cure.
Diabetes is recognised as posing a serious global threat. With around 6 million newly diagnosed each year, it is anticipated that by 2040 more than 640 million people worldwide, will be affected by the condition.
Whilst stem cell research is still really in its infancy in many ways, there is much evidence to suggest that it could significantly speed up a discovery of a cure for diabetes.
In the long term it is believed that stem cell research could lead to the development of many new treatments for a wide range of diseases but there is certainly still a long way to go in this research area, before treatments would be available.
DRWF recognises that there are important ethical issues that must be taken into account when considering all aspects of stem cell research. It is vitally important that appropriate safeguards and limitations are in place and the United Kingdom has a comprehensive and well established framework for stem cell research. Embryonic stem cell research is allowed subject to license from the Human Fertilisation and Embryonic Authority (HFEA).
The aim of medical research is to relieve suffering and improve the quality of life for people in ill health, many of whom may die prematurely. With this in mind, DRWF supports the continued investigation of stem cell research, within the strict and rigorous regulatory framework, in which medical researchers are required to carry out their work.
DRWF Position Statement - December 2016